Common Contracts
7 similar Underwriting Agreement contracts by Durect Corp, Celator Pharmaceuticals Inc, Inhibitex, Inc., others
DURECT CORPORATION 12,000,000 Shares Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • April 29th, 2016 • Durect Corp • Pharmaceutical preparations • New York
Durect Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”) an aggregate of 12,000,000 shares (the “Firm Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The Firm Shares include 360,000 shares of Common Stock (the “Other Firm Shares”) to be purchased by a person previously agreed upon between the Company and the Underwriters. The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, up to an additional 1,800,000 shares of common stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
4,000,000 Shares Celator Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 23rd, 2016 • Celator Pharmaceuticals Inc • Pharmaceutical preparations • New York
DURECT CORPORATION 7,142,858 Shares Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • November 13th, 2013 • Durect Corp • Pharmaceutical preparations • New York
Durect Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”) an aggregate of 7,142,858 shares (the “Firm Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The Firm Shares include 714,285 shares of Common Stock (the “Other Firm Shares”) to be purchased by a person previously agreed upon between the Company and the Underwriters. The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, up to an additional 1,071,429 shares of common stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
6,956,522 Shares Speed Commerce, Inc. (f/k/a Navarre Corporation) Common Stock (No Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • September 26th, 2013 • Speed Commerce, Inc. • Wholesale-computers & peripheral equipment & software • New York
Speed Commerce, Inc. (f/k/a Navarre Corporation), a Minnesota corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”) for whom you are acting as representative (the “Representative”), an aggregate of 6,956,522 shares (the “Firm Shares”) of common stock, no par value per share, of the Company (the “Common Stock”). The Company also proposes to sell to the several Underwriters, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, up to an additional 1,043,478 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
2,030,000 Shares MEI PHARMA, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 10th, 2013 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
MEI Pharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”) for whom you are acting as representatives (the “Representatives”), an aggregate of 2.030,000 shares (the “Shares”) of common stock, par value $0.00000002 per share, of the Company (the “Common Stock”).
2,632,000 Shares PROCERA NETWORKS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2011 • Procera Networks Inc • Services-computer programming services • New York
Procera Networks, Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”) for whom you are acting as representative (the “Representative”), an aggregate of 2,632,000 shares (the “Firm Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”). The Company also proposes to sell to the several Underwriters, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, up to an additional 394,800 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
11,463,415 Shares INHIBITEX, INC. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • April 7th, 2011 • Inhibitex, Inc. • Biological products, (no disgnostic substances) • New York
Inhibitex, Inc.., a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representative (the “Representative” or “you”) an aggregate of 11,463,415 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to 1,719,512 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below. The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively called the “Shares.”
